| 产品编号 | 产品名称 | CAS No. | 
| DC8258 | Baricitinib phosphate Baricitinib phosphate(INCB 028050; LY 3009104) is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2,showed potent activity against COVID-19(SARS-COV-2). | 1187595-84-1 | 
| DC8526 | PF4618433 PF-4618433 shows improved PYK2 potency, reduced p38 activity, and superior overall selectivity relative to the prototype BIRB796. | 1166393-85-6 | 
| DC8729 | Bifeprunox Bifeprunox is a Dopamine D2 and 5-HT1A partial agonist in development as a potential treatment for schizophrenia and other psychotic indications. | 350992-10-8 | 
| DC8983 | Ibudilast Ibudilast(KC-404;AV-411;MN-166) is a relatively nonselective phosphodiesterase inhibitor which has been marketed for treating asthma,ibudilast (MN-166) is tested to treat acute respiratory distress syndrome (ARDS) associated with Covid-19. | 50847-11-5 | 
| DC9098 | Paroxetine HCl Paroxetine hydrochloride hemihydrate is a antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). | 110429-35-1 | 
| DC9180 | Tamoxifen Citrate Tamoxifen(ICI-46474) is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen,showed potent activity against COVID-19(SARS-COV-2) with EC50 MERS-COV(10.117), SARS-COV(11.696). | 54965-24-1 | 
| DC9474 | Nelfinavir (Mesylate) Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. | 159989-65-8 | 
| DC9475 | Ritonavir Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS,showed potent activity against COVID-19(SARS-COV-2) . | 155213-67-5 | 
| DC9619 | Nafamostat (mesylate) Nafamostat mesylate, a synthetic serine protease inhibitor, is an anticoagulant,showed highly potent activity against COVID-19(SARS-COV-2). | 82956-11-4 | 
| DC9743 | CB1954(Tretazicar) CB1954(Tretazicar) in stock,price: 350 USD/100mg. CB1954(Tretazicar) is a anticancer prodrug that is converted in the presence of the enzyme NQO2 and co-substrate caricotamide ( EP-0152R) (EP) into a potent cytotoxic bifunctional alkylating agent.It can | 21919-05-1 | 
| DC9887 | FRAX1036 FRAX1036 is a novel ATP-competitive small molecule inhibitor of group I p21-activated Kinases (PAKs). | 1432908-05-8 | 
| DCAPI1085 | Clevudine (Levovir) Clevudine (Levovir) is an antiviral drug for the treatment of hepatitis B,showed potent activity against COVID-19(SARS-COV-2) . | 163252-36-6 | 
| DCAPI1165 | Ribavirin (Copegus) Ribavirin is a guanosine analog with antiviral properties against DNA and RNA viruses, including respiratory syncytial virus, hepatitis C, and influenza. | 36791-04-5 | 
| DCAPI1390 | Atovaquone (Atavaquone) Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia. | 95233-18-4 | 
| DCAPI1505 | Darunavir Darunavir(TMC114) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2) . | 206361-99-1 | 
| DC8759 | Thiamet G Thiamet G is a potent and selective inhibitor of O-GlcNAcase that demonstrates a Ki value of 21 nM. | 1009816-48-1 | 
| DCAPI1051 | Arbidol HCl (Umifenovir) Arbidol hydrochloride (Umifenovir hydrochloride) is an potent inhibitor of COVID-19. | 131707-23-8 | 
| DC10019 | VPS34 inhibitor 1 (Compound 19, PIK-III analogue) VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM. | 1383716-46-8 | 
| DC10052 | Bisindolylmaleimide X(Ro 31-8425) Bisindolylmaleimide X is a cell-permeable, reversible, ATP-competitive protein kinase C (PKC) inhibitor (IC50 = 15 nM, rat brain PKC). | 1241725-89-2 | 
| DC1006 | OSI-027 OSI-027 is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, respectively. | 936890-98-1 | 
| DC10065 | Takeda-6d Takeda-6d has potent inhibitory activity in both B-RAF with an IC50 of 7.0 nM and VEGFR2 with an IC50 of 2.2 nM. | 1125632-93-0 | 
| DC1012 | Macitentan (Actelion-1,ACT-064992) macitentan (Actelion-1, ACT-064992) is an orally active, non-peptide dual endothelin (ET)A/B receptor antagonist with IC50 of 0.5 nM/391 nM. | 441798-33-0 |